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0022-2836 © 2010 Elsevier Ltd. Open acceMammalian pyruvate dehydrogenase complex (PDC) is a key multi-
enzyme assembly that is responsible for glucose homeostasis maintenance
and conversion of pyruvate into acetyl-CoA. It comprises a central
pentagonal dodecahedral core consisting of two subunit types (E2 and
E3BP) to which peripheral enzymes (E1 and E3) bind tightly but non-
covalently. Currently, there are two conflicting models of PDC (E2+E3BP)
core organisation: the ‘addition’model (60+12) and the ‘substitution’model
(48+12). Here we present the first ever low-resolution structures of human
recombinant full-length PDC core (rE2/E3BP), truncated PDC core (tE2/
E3BP) and native bovine heart PDC core (bE2/E3BP) obtained by small-
angle X-ray scattering and small-angle neutron scattering. These structures,
corroborated by negative-stain and cryo electron microscopy data, clearly
reveal open pentagonal core faces, favouring the ‘substitution’ model of
core organisation. The native and recombinant core structures are all similar
to the truncated bacterial E2 core crystal structure obtained previously.
Cryo-electron microscopy reconstructions of rE2/E3BP and rE2/E3BP:E3
directly confirm that the core has open pentagonal faces, agree with
scattering-derived models and show density extending outwards from their
surfaces, which is much more structurally ordered in the presence of E3.
Additionally, analytical ultracentrifugation characterisation of rE2/E3BP,
rE2 (full-length recombinant E2-only) and tE2/E3BP supports the substi-
tution model. Superimposition of the small-angle neutron scattering tE2/
E3BP and truncated bacterial E2 crystal structures demonstrates conserva-
tion of the overall pentagonal dodecahedral morphology, despite evolu-
tionary diversity. In addition, unfolding studies using circular dichroism
and tryptophan fluorescence spectroscopy show that the rE2/E3BP is less
stable than its rE2 counterpart, indicative of a role for E3BP in core
destabilisation. The architectural complexity and lower stability of the E2/
E3BP core may be of benefit to mammals, where sophisticated fine-tuning is
required for cores with optimal catalytic and regulatory efficiencies.
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Mitochondrial 2-oxoacid dehydrogenase com-
plexes are a family of stable macromolecular
machines (Mr=4–10 million) that serve as models
for the study of protein–protein interactions, en-
zyme cooperativity and active-site coupling. Princi-
pal members include the pyruvate dehydrogenase
complex (PDC), 2-oxoglutarate dehydrogenase com-
plex (OGDC) and branched-chain 2-oxoacid dehy-
drogenase complex. The lipoamide prosthetic group
[on E2 (dihydrolipoamide acetyltransferase) and
E3BP (E3 binding protein) in PDC] assists all three
complexes in their catalytic function via its ‘swing-
ing-arm’ mechanism, visiting all the active sites
during the multi-step reaction cycle.1,2 PDC links
glycolysis with the tricarboxylic acid cycle, catalys-
ing the irreversible decarboxylation of pyruvate to
acetyl-CoA, the key committed step in carbohydrate
utilisation in mammals.3 In recent years, PDC and
OGDC defects have been implicated in several
genetic and physiological disorders, including met-
abolic acidosis,4–6 diabetes7–9 and primary biliary
cirrhosis;10–12 neurodegenerative conditions such as
Alzheimer's disease;13–16 and other disorders linked
to oxidative stress.17
PDC comprises multiple copies of three distinct
enzymes: E1 (pyruvate decarboxylase), E2 and E3
(dihydrolipoamide dehydrogenase). In addition,
eukaryotic PDC contains a unique subunit, termed
E3BP,18,19 that has no known enzymatic function.
The central core of PDC is made up of E2 (and E3BP
in eukaryotes), forming either a 24-meric octahedron
(in Gram-negative bacteria) or a 60-meric pentago-
nal dodecahedron (in eukaryotes and Gram-positive
bacteria).20,21 Thus, E2 provides the structural and
organisational framework upon which the assembly
and function of the entire complex are dependent, in
addition to its role in catalysis. The E2 core interacts
with both E1 and E3 in a mutually exclusive fashion
in bacteria,2,22 whereas in eukaryotes, E3BP specif-
ically mediates stable E3 integration.18,19 Interest-
ingly, the PDC of patients totally lacking E3BP
displays 10–20% of wild-type activity and appears
to retain a residual affinity for E3.23karyotic E2 and E3BP. Clu
3BP [human (h), yeast (y)
an E2 and E3BP, along w
d of domains, and the lip
trimeric units are also in
talogue/entries/texshadeHuman E2 and E3BP have similar modular
domain organisations. They both comprise highly
flexible N-terminal lipoyl domains (LDs; two on E2
and one on E3BP), followed by a subunit binding
domain (SBD) and a C-terminal domain (CTD) that
is involved in core assembly (Fig. 1). These modular
domains are connected by Ala-Pro-rich linkers that
confer mobility to the peripherally extended LDs
such that their covalently bound lipoamide cofactors
can serve as substrates for all three constituent
enzymes in turn during catalysis. PDC is acutely
regulated by tightly bound kinases (phosphoinosi-
tide-dependent protein kinases) and loosely bound
phosphatases (pyruvate dehydrogenase phospha-
tases) that act in concert to control its activity state.24
Phosphoinositide-dependent protein kinase is a
major drug target, as activation of PDC by limiting
phosphorylation can alleviate impaired carbohy-
drate metabolism in severe diabetes.
Several structures of the individual domains (LD,
SBD and CTD) of E2 PDC have been solved to high
resolution.25–29 Of most relevance to this study are
the crystal structures of the truncated E2 CTD [tE2
(truncated E2-only PDC core)] of Azotobacter
vinelandii30 and Bacillus stearothermophilus.28 The
high-resolution crystal structure of the truncated
core from B. stearothermophilus [Protein Data Bank
(PDB) ID 1B5S], in particular, provides clear insights
into its subunit organisation, with the basic building
blocks (namely, truncated E2 trimers) located at the
20 vertices of the icosahedron28 interconnected by 30
flexible bridges that enable the core to ‘breathe’, as
evidenced by a size variability of 20%.31 A recent
cryo electron microscopy (EM) reconstruction of
truncated recombinant human E2 has also been
determined.32 However, there is as yet no structure
for the human E2/E3BP assembly, probably owing
to its massive size, significant N-terminal flexibility
and subunit heterogeneity. Moreover, the precise
subunit composition and arrangement of E2 and
E3BP subunits around its pentagonal dodecahedral
core are still unclear, as is the stoichiometry of E1 and
E3 binding.
Previous densitometry and radiolabelling studies
of purified bovine E2/E3BP indicated the presencestalW (http://www.ebi.gla.ac.uk/clustalw) alignment of
and B. stearothermophilus (bst)]. LDs, linker regions (H1 and
ith the consensus sequence (red), are indicated. Sequence
oylation site (⁎) and key residues mediating the ‘ball-and-
dicated. The image was created using TEXshade (http://
.html).
Fig. 1 (legend on previous page)
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74 Architecture of the Human PDC Core Assemblyof 12 E3BP molecules per core, suggestive of an
icosahedral E2/E3BP assembly comprising 60 copies
of E2 and 12 copies of E3BP.33 Similarly, Maeng et al.
showed the binding of 12–15 E3BP molecules to the
E2 core of Saccharomyces cerevisiae PDC.34 Compar-
ative cryo-EM studies of truncated yeast E2 and E2/
E3BP cores indicated the localisation of 12 E3BP
molecules to the pentagonal faces, giving rise to the
60E2+12E3BP ‘addition model’.35,36 However, the
recent work of Hiromasa et al. based on analytical
ultracentrifugation (AUC) and small-angle X-ray
scattering (SAXS) has led to the development of an
alternative ‘substitution model’ wherein 12 E2
polypeptides are replaced by 12 E3BP subunits,
resulting in a 48E2+12E3BP core assembly.37 Vari-
ation in the subunit organisation of the yeast and
human PDC cores has been attributed to the
dissimilarity of their E3BP sequences (Fig. 1).35,37
Recently, a second version of the ‘substitution
model’ has proposed a 40E2+20E3BP composition
based on isothermal titration calorimetry and AUC
data.38
In the absence of detailed structural information,
our current knowledge of the architecture, subunitFig. 2. SV analysis of rE2/E3BP, rE2 and tE2/E3BP. c(s) di
collected over a range of sample concentrations for (a) rE2/E3
tE2/E3BP (s20,w
0 =27.5±0.03 S). (d) Determination of the concen
species. Error bars are shown but are not clearly visible owinorganisation and functional properties of the human
E2/E3BP core assembly remains limited. Moreover,
no solution structures for the full-length recombi-
nant or native mammalian core assemblies are
available at present. In this context, the specific
aims of this study were as follows:
(1) To employ SAXS and small-angle neutron
scattering (SANS) technologies to obtain the first
low-resolution structures of full-length recombi-
nant human and native bovine E2/E3BP cores and
the truncated humanE2/E3BP equivalent. Thiswill
permit (a) direct comparison between them, and (b)
assessment of their similarity to the published
crystal structure of B. stearothermophilus tE2.
(2) To test the hypothesis that the human E2/
E3BP core assembles via a ‘substitution’—and not
‘addition’—mechanism.
(3) To undertake a parallel cryo-EM evaluation of
the recombinant full-length E2/E3BP core in the
presence or in the absence of bound E3 (a) to
make a direct comparison with the equivalent
SAXS/SANS structures and, in so doing, test the
hypothesis that cryo-EM imaging misses keystributions derived via SEDFIT from SV interference data
BP (s20,w
0 =29.3±0.04 S), (b) rE2 (s20,w
0 =29.3±0.02 S) and (c)
tration-independent sedimentation coefficient for the main
g to their small size.
Ta
Co
rE2
rE2
tE2
M
exp
to t
is t
75Architecture of the Human PDC Core Assemblyfeatures that can be detected by SAXS studies, and
(b) to analyse the possible effects of E3 binding on
the organisation of the peripherally located E3BP-
linked SBDs and LDs.
(4) To determine for rE3BP its molecular mass
and propensity for self-association (by AUC) and
to assess its influence on core stability by
monitoring differences between the profiles of
GdmCl-induced E2 core and E2/E3BP core
dissociation using circular dichroism (CD) and
tryptophan fluorescence spectroscopy. In so
doing, the hypothesis that E3BP destabilises the
E2/E3BP core assembly will be tested.Results
AUC analysis of recombinant cores rE2/E3BP,
rE2 and tE2/E3BP
The hydrodynamic and thermodynamic behav-
iour of the recombinant PDC cores was determined
via sedimentation velocity (SV) and sedimentation
equilibrium (SE) AUC. SV of rE2/E3BP (recombi-
nant full-length PDC core; Fig. 2a), rE2 (recombinant
full-length E2-only PDC core; Fig. 2b) and tE2/E3BP
(recombinant truncated PDC core; Fig. 2c) revealed
a main species whose sedimentation coefficient is
consistent with that of a 60-meric core. Additionally,
a trailing edge corresponding to a small amount
(≤5% of total) of high-molecular-mass species was
also observed. Weight-average sedimentation coef-
ficients sw were determined to be 29 and 43 S (rE2/
E3BP), 28.5 and 47 S (rE2), and 27 and 38 S (tE2/
E3BP) by integration of each peak in c(s) analysis.
While the sw of the major peak for rE2/E3BP (29 S)
compares favourably with the sedimentation coeffi-
cient of 31.8 S obtained by Hiromasa et al.,37 the sw of
rE2 (28.5 S) is slightly lower than the value (36.0 S)
they reported37 and may reflect the different
approaches employed in sample preparation and
data analysis. Finite-element analysis with the non-
interacting discrete species model in SEDFIT yielded
sedimentation coefficients for all three cores (rE2/
E3BP, rE2 and tE2/E3BP) at all experimental
concentrations. These were corrected to standard
conditions and extrapolated to infinite dilution,
giving concentration-independent sedimentation
coefficients s20,w
0 (Fig. 2d) of 29.3±0.04 S (rE2/
E3BP), 29.3±0.02 S (rE2) and 27.5±0.03 S (tE2/ble 1. Hydrodynamic parameters for recombinant cores d
re M (Da) v̄ (ml/g) s20,w
0 (S) f/
/E3BP 3,551,100 0.744 29.3 2
3,741,780 0.744 29.3 2
/E3BP 1,671,348 0.746 27.5 1
is the molecular mass based on amino acid composition; v̄ is the ca
erimental sedimentation coefficient at infinite dilution;R0 is the rad
he core in question; Rs is the hydrodynamic or Stokes radius;Ds is t
he translational diffusion coefficient.E3BP). Interestingly, the c(s) profile and sedimenta-
tion coefficient of tE2/E3BP (27.5 S; Fig. 2c) are
comparable with SV data for full-length rE2/E3BP
(29.3 S; Fig. 2a) and rE2 (29.3 S; Fig. 2b). Therefore, it
can be inferred that the decrease in particle radius
(and, as a consequence, the decrease in frictional
drag) of tE2/E3BP is offset by the decrease in its
molecular mass; thus, its sedimentation behaviour
remains largely unchanged, compared with the full-
length cores. The observed tail at higher s may
correspond to the presence of aggregates or a small
fraction of putative dimer that was persistent in all
SV runs and has been observed previously.37,39
However, it was not possible to improve fits to the
data with a monomer–dimer model; thus, the dimer,
if real, may be irreversible. Moreover, the peaks
corresponding to the intact 60-meric cores are quite
broad and probably reflect inherent heterogeneity
due to variation in the size of E2/E3BP cores,
possibly as a result of the ‘breathing’ phenomenon
observed previously31 (see Discussion).
Frictional ratios (f/f0) were derived from s0/s20,w
0
(i.e., the ratio of the sedimentation coefficient of an
anhydrous sphere of mass and volume equal to the
core in question to the experimentally measured
sedimentation coefficient). The resultant values
(2.69, 2.79 and 1.73 for rE2/E3BP, rE2 and tE2/
E3BP, respectively; Table 1) were consistent with the
values obtained from c(s) analysis of SV data. f/f0
reflects experimental hydrodynamic hydration and
deviation from sphericity. The large values of f/f0
for the full-length cores indicate structures with
either significant deviation from spherical symmetry
and/or significant hydration. The frictional ratios of
rE2/E3BP and rE2 are almost indistinguishable
from each other, but both are significantly greater
than that of tE2/E3BP. This reflects the increase in
deviation from the sphericity of the full-length cores
due to their extended N-terminal domains.
The diameter of tE2/E3BP (Ds=27.4 nm, derived
from its hydrodynamic radius) is larger than the
previously reported values of the average diameter,
ranging from 21 to 24 nm.40–42 However, this
elevated value is well within the 20% variability
attributed to the ‘breathing’ of the inner core.31 At its
N terminus, tE2/E3BP includes the 19-amino-acid
and 30-amino-acid segments of the inner linker
regions preceding the CTDs of E2 and E3BP,
respectively. These extra linker regions will be located
outside of the dodecahedron and will contribute to
the hydrodynamic diameter of tE2/E3BP.erived from SV data
f0 R0 (Å) Rs (Å) Ds (Å) Dt (cm
2/s)
.69 102 273 546 8.10×10−8
.79 103 288 576 7.68×10−8
.73 791 137 274 1.569×10−7
lculated partial specific volume at 20 °C; s20,w
0 is the standardised
ius of an anhydrous sphere of mass and specific volume equivalent
he diameter of the particle obtained from the Stokes radius; andDt
Fig. 3 (legend on next page)
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Fig. 3. SE analysis of rE2/E3BP, rE2 and tE2/E3BP.
Best fits (smooth lines) to the SE interference data (dotted
lines) for (a) rE2/E3BP, (b) rE2 and (c) tE2/E3BP at
3000 rpm using a two-species model in SEDPHAT.
Residual plots are shown beneath each fit. Mapp was
determined at each sample concentration. (d) Extrapola-
tion of the 1/Mapp-versus-concentration plot of the
predominant species to zero yielded the molecular mass
Mw
0 independent of concentration for rE2/E3BP
(2.56 MDa), rE2 (3.06 MDa) and tE2/E3BP (1.65 MDa).
Fig. 4. SDS-PAGE of post-SE rE2/E3BP and rE2 samples.
(lanes 1–7) were analysed by SDS-PAGE and show several b
rE3BP. The different lanes represent the various concentration
rE2 are shown for comparison. Molecular masses of marker p
77Architecture of the Human PDC Core AssemblyGlobal analysis of SE data by SEDPHAT43,44 with
a single-species model yielded very poor fits that
were greatly improved upon using a two-species
model, giving molecular masses of 2.48 and
5.71 MDa (rE2/E3BP; Fig. 3a) and 2.78 and
4.59 MDa (rE2; Fig. 3b) for the predominant
(∼90% of total) and minor (∼10% of total) species,
respectively. The molecular mass of the predomi-
nant species independent of concentration Mw
0 (Fig.
3d) was determined to be 2.57±0.24 MDa (rE2/
E3BP) and 3.06±0.25 MDa (rE2), lower than their
predicted molecular masses of 3.55 MDa (based on
the 48E2+12E3BP model) and 3.74 MDa, respec-
tively. This discrepancy could reflect the formation
of incomplete cores or proteolytic cleavage of the N-
terminal arms of rE2/E3BP and rE2 over the
experimental time period (∼3 days) required for
the SE runs. However, negative-stain EM images
(see the text below) of the samples prior to SE show
complete cores; therefore, proteolytic cleavage dur-
ing the course of the SE run is the more likely
explanation. In our experience, full-length rE2/E3BP
and rE2, particularly the flexible linker regions
connecting the various domains, are highly suscep-
tible to proteolysis over time. For example, gel-
filtration chromatography (GFC) of 4-day-old rE2/Post-SE samples of (a) rE2/E3BP (lanes 1–7) and (c) rE2
ands relating to proteolytic products (arrows) of rE2 and
s of samples used. Freshly purified (b) rE2/E3BP and (d)
roteins (Mw) are indicated in kilodaltons.
Fig. 5. SAXS/SANS of rE2/E3BP, bE2/E3BP and tE2/
E3BP. Scattering curves, together with distance distribu-
tion functions p(r) versus r, calculated using GNOM
(insets) for (a) rE2/E3BP, (b) bE2/E3BP and (c) tE2/
E3BP are shown. Error bars shown on the p(r) plots are not
clearly visible owing to their small size.
78 Architecture of the Human PDC Core AssemblyE3BP resulted in the elution of several low-molecular-
mass products (data not shown). This proteolytic
cleavage is clearly seen on SDS-PAGE of post-SE
rE2/E3BP and rE2 samples (Fig. 4a and b). rE2 and
rE3BP migrate more slowly than expected on SDS-
PAGE because they contain a large number of
proline and alanine residues in their interdomain
linkers that are thought to swell and induce bul-
kiness in the LDs.45,46 Apart from the expected
monomeric rE2 (61 kDa) and rE3BP (50 kDa), SDS-
PAGE reveals truncates with molecular masses of
50–60 kDa, 43 kDa (possibly SBD–CTD), 29 kDa
(possibly CTD) and 20–25 kDa.
Global fitting of SE data yielded molecular masses
of 5.71 and 4.59 MDa, respectively, for the minor
species, lower than expected for a dimer of intact 60-
meric rE2/E3BP (7.1 MDa) or rE2 (7.48 MDa) (data
not shown) and not consistent with dimers of
proteolytically cleaved cores. Moreover, the SE
data could not be satisfactorily modelled with the
self-association model in SEDPHAT, indicating that
these minor species are aggregates rather than core
dimers or other higher-order oligomers, consistent
with the higher s tail observed in c(s) analysis of SV
data (Fig. 3). Despite several attempts to minimise
the extent of proteolytic degradation during purifi-
cation by inclusion of protease inhibitors at all
stages, the molecular masses of the cores were
always in the range of 2.5–2.7 MDa (rE2/E3BP) and
3.0–3.1 MDa (rE2).
Analysis of the SE data for tE2/E3BP was carried
out using a two-species model in SEDPHAT43,44
(Fig. 3c). Extrapolation of 1/Mapp to infinite dilution
for the predominant species (∼99% of total) gave
Mw
0 =1.65±0.03 MDa (Fig. 3d), in good agreement
with the value predicted from the tE2/E3BP amino
acid sequence (1.67 MDa, based on the 48E2+
12E3BP model), in support of the hypothesis that
the human E2/E3BP core assembles via a ‘substi-
tution’—and not ‘addition’—mechanism. Interest-
ingly, because this truncated core lacks the N-
terminal domains that are prone to proteolytic
cleavage (as seen for rE2/E3BP and rE2), the
experimentally determined molecular mass exactly
matches that computed from the amino acid
sequence. Global analysis and fitting for the minor
species (∼1% of total) yielded a molecular mass of
2.29 MDa (data not shown), notably lower than that
of the possible tE2/E3BP dimer (3.34 MDa, based
on the 48E2+ 12E3BP model). In addition, fitting
with the self-association model in SEDPHAT was
unsatisfactory, suggesting the formation of minor
aggregates rather than the presence of higher-order
oligomers.
SAXS and SANS measurements of rE2/E3BP,
bE2/E3BP, and tE2/E3BP
SAXS data for rE2/E3BP and bE2/E3BP (native
bovine PDC core) were acquired at various concen-
trations and temperatures (see Materials and Meth-
ods). The high-concentration samples aggregated,
and the scattering curves from the low-concentrationsamples were dominated by noise. However, data
obtained at concentrations of 830.9 nM (rE2/E3BP;
Fig. 5a) and 183.1 nM (bE2/E3BP; Fig. 5b) were
devoid of scattering from aggregates, interparticle
interference effects, temperature-induced conforma-
tional changes or radiation-induced damage, and
hence were used for ab initio modelling.
Guinier analysis and GNOM47,48 were employed
to determine the radius of gyration Rg for rE2/E3BP
(147±1 and 148±1 Å) and bE2/E3BP (158±1 and
Fig. 6. Solution structures of rE2/E3BP by negative-
stain EM. Negative-stain EM of rE2/E3BP shows complete
icosahedral cores with empty (pentagonal) faces. Orienta-
tion of cores along the 5-fold (arrow), 3-fold (square) and
2-fold (circle) axes is indicated.
79Architecture of the Human PDC Core Assembly156±1 Å). The distance distribution functions p(r)
for rE2/E3BP and bE2/E3BP (Fig. 5a and b, insets)
are generally bell shaped, but with slight deviations
from the perfect Gaussian distribution (indicative of
a spherical molecule), especially at high values of r.
The maximum particle diameter Dmax was deter-
mined to be 472 Å (rE2/E3BP) and 480 Å (bE2/
E3BP), both much greater than the diameter of the
native bovine heart and kidney E2/E3BP cores
determined previously by cryo-EM (225 Å in the 5-
fold orientation)42 probably because the extended
flexible N-terminal domains have been imaged by
SAXS, but not by this early cryo-EM study. The Rg
(147±1 Å) of rE2/E3BP is consistent with that
determined by Hiromasa et al. (151±2 Å), although
the Dmax they measured was lower (420±10 Å).37
SANS curves were acquired for tE2/E3BP at
three protein concentrations to account for inter-
particle interference effects. However, protein ag-
gregation was observed for the highest sample
concentration (712.6 nM), while data at the lowest
concentration (161.7 nM) yielded insufficient signal-
to-noise ratio. However, the scattering curve ob-
tained at 353.3 nM showed no evidence of aggre-
gates (Fig. 5c) and was used as data set for ab initio
modelling. The Rg determined using Guinier
analysis was 107± 2 Å. The p(r) distribution
function is shown in Fig. 5c (inset). The Dmax is
300 Å, and the Rg calculated from the p(r) function
is 111±2 Å, which agrees well with the value
obtained from Guinier analysis.
Low-resolution solution structures of human
E2/E3BP cores
Negative-stain EM of rE2/E3BP (Fig. 6) revealed a
uniform distribution ofwell-formed icosahedral core
structures with empty pentagonal faces, consistent
with previous EM images for bovine heart PDC.42
Similar EM images of hollow cores with empty
pentagonal faces were obtained for tE2/E3BP (datanot shown). Core structures were clearly visible,
exhibiting the underlying 5-fold, 3-fold and 2-fold
structural symmetries (Fig. 6), although cores were
more commonly imaged along the 5-fold axis,
consistent with cryo-EM data for bE2/E3BP.42 This
observation of empty pentagonal faces provides
strong support for the ‘substitution model’ of the
human E2/E3BP core assembly.
Ab initio models of rE2/E3BP (Fig. 7a) and bE2/
E3BP (Fig. 7c) were generated from SAXS data with
the program GASBOR49,50 by employing icosahe-
dral symmetry and various penalty constraints
during the modelling process (see Materials and
Methods). Two hundred GASBOR runs were con-
ducted to obtain consistent models (Fig. 7b and d).
Several model families that satisfied the search
volume were generated, but not all were consistent
with structures observed with EM (i.e., dodecahe-
dral structures with large hollow central cavities and
empty pentagonal faces). Models similar to our own
(Fig. 6) and published EM images42 were chosen for
further analysis to obtain consensus models for both
rE2/E3BP and bE2/E3BP. These consensus models
were obtained by the superimposition of 10 ab initio
GASBOR models for each of the cores (rE2/E3BP
and bE2/E3BP; see Materials and Methods) in
which the key structural features, such as the hollow
cavities and extended peripheral arms, are pre-
served (Fig. 7). The positions of rE3BP within the
cores cannot be ascertained from these models.
Greater electron density is observed within the inner
part of the core than in the peripheral flanking arms.
This may be a consequence of the GASBOR
algorithm favouring compactness. These limitations
notwithstanding, the ab initio models clearly sup-
port the hypothesis that the human E2/E3BP core
assembles via a ‘substitution’—and not ‘addition’—
mechanism.
Ab initio restoration of a model for tE2/E3BP from
SANS data using GASBOR49,50 produced an icosa-
hedral core with hollow internal cavities and empty
pentagonal faces (Fig. 8a). No density was observed
within the pentagonal faces, as would occur if the
CTD of E3BP were added to the inner or outer
surface of the E2 core, as observed in yeast,35 thus
strongly supporting the ‘substitution’ model of core
organisation. Moreover, the solution structure of
tE2/E3BP is consistent with the ‘inner core’ SAXS
structures of full-length rE2/E3BP and bE2/E3BP
(Fig. 7), as well as with the structures of bE2/E3BP42
and human tE232 obtained from cryo-EM studies.42
Ten ab initio GASBOR models were successfully
averaged using DAMAVER51 to obtain a consensus
average structure of tE2/E3BP.
Hydrodynamic and homology modeling of
recombinant cores
Hydrodynamic bead models (HBMs) of rE2/E3BP
and tE2/E3BP were generated from the ab initio
models using the programs AtoB52 and TRANS2-
VORONOI (see Materials and Methods). Assuming
a hydration of 0.4 g water/g protein, hydrated
Fig. 7. Solution structures of rE2/E3BP and bE2/E3BP by ab initio modeling from SAXS data. Single GASBOR
reconstructions obtained from SAXS: (a) rE2/E3BP along the 5-fold axis of symmetry, and (c) bE2/E3BP along the 2-fold
axis of symmetry. Ten single ab initio GASBOR reconstructions were superimposed to yield consensus models that
preserved all key structural features of (b) rE2/E3BP (visualised along the 2-fold axis of symmetry) and (d) bE2/E3BP
(visualised along the 5-fold axis of symmetry).
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28.2 S (tE2/E3BP)were calculated using the program
HYDRO++,53,54 in excellent agreement with the
experimental values of 29.3 S (rE2/E3BP) and
27.5 S (tE2/E3BP) obtained from SV data. Addition-
ally, the sedimentation coefficient of B. stearothermo-
philus tE2 was calculated for an HBM (generated
from its atomic coordinates28 using AtoB52) using
the program HYDRO++.53,54 On applying the hy-
dration factor for 0.4 g water/g protein (0.87; see
Materials and Methods), a sedimentation coefficient
of 29.9 S was obtained for B. stearothermophilus tE2,
slightly higher than the experimentally determined
value of 27.5 S for tE2/E3BP. This difference is not
likely to be the result of any difference in hydration,
since the amino acid compositions of B. stearothermo-
philus tE2 and human tE2/E3BP are highly similar.
Instead, it may indicate a more flexible open
conformation for tE2/E3BP in solution, in compar-ison with the crystal structure for the bacterial
truncate, stemming from so-called crystal packing
effects. More importantly, it may also reflect
slight differences in overall structures arising as a
consequence of E3BP integration into the human E2
core.
In addition to AUC, SAXS and SANS, homology
modelling was carried out to gain more insight into
the human tE2 structure. The crystal structure of B.
stearothermophilus tE2 (green; Fig. 8b) was used as
template to generate the homology model of human
tE228 (blue; Fig. 8c). Superimposition of the ab initio
SANS model of tE2/E3BP onto the crystal structure
of B. stearothermophilus tE228 (Fig. 8b) and the
homology model of human tE2 (Fig. 8c) using
SUPCOMB55 indicates good conservation of the
gross structural features of the icosahedral core.
The superimpositions indicate that despite variable
regulatory functions and some minor structural
Fig. 8. Solution structure of tE2/E3BP and its superimposition with the B. stearothermophilus tE2 crystal structure and a
homology model of human tE2. The ab initio model of tE2/E3BP (generated from SANS data using GASBOR) is shown
along the (a) 2-fold axis of symmetry. Superimposition of the ab initio model of tE2/E3BP (red) with (b) the crystal
structure of B. stearothermophilus tE2 (green) and (c) the homology model of human tE2 (blue) indicates an overall
conservation of icosahedral topology. (d) Overlay of the scattering curves of the ab initio SANS model of human tE2/
E3BP and the crystal structure of bacterial tE2 using CRYSOL.
81Architecture of the Human PDC Core Assemblydifferences (confined mainly to the hairpin domain
and the N-terminal helix connected to the linker
region preceding the CTD32), the overall icosahedral
framework of the human E2/E3BP and B. stearother-
mophilus E2 CTD cores is highly conserved. Further-
more, intensity scattering curves calculated (using
CRYSOL56) for the ab initio human tE2/E3BPmodel
and the crystal structure of B. stearothermophilus tE2
are in good agreement with each other in the low-
angle region of scattering that reflects overall
molecular shape (Fig. 8d). The curves differ at
wider angles because they originate from structures
that are fundamentally different at this resolution
(i.e., a crystal structure versus a dummy residue
model).Cryo-EM reconstruction of cores
Images of rE2/E3BP and rE2/E3BP:E3 cores
obtained under low-dose conditions using cryo-
EM were subjected to three-dimensional reconstruc-
tion, as described in Materials and Methods. The
refined maps show the well-defined dodecahedral
geometry associated with PDC complexes, into
which the crystal structure of the B. stearothermophi-
lus E2 protein core fits well (Fig. 9a and b). When the
density threshold for both rE2/E3BP and rE2/E3BP:
E3 maps is set such that the core density super-
imposes, prominent and well-defined spikes remain
extended from the latter structure, which are absent
from the former (Fig. 9a). When the contour level of
Fig. 9. Cryo-EM of the full-length rE2/E3BP and rE2/E3BP:E3 complexes. (a) Cryo-EM reconstructions of the rE2/
E3BP (semi-transparent surface) and E2/E3BP:E3 core (mesh), with the crystal structure of the B. stearothermophilus E2
core fitted within (green ribbon). The contour level of rE2/E3BP was chosen to match that of the complex with E3. (b) The
E2/E3BP:E3 core only superimposed with the crystal structure of the B. stearothermophilus E2 core (green ribbon) for
clarity. (c) The E2/E3BP core at a lower contour level showing the presence of satellite density, which represents relatively
disordered regions of E2 and E3BP, superimposed on E2/E3BP:E3 in which these regions become ordered on E3 binding.
(d) Close-up of the surface of the rE2/E3BP:E3 structure reported here (mesh) and the GASBOR-derived rE2/E3BP ab
initio SAXS model (red). Extensions from the core surface found in SAS data agree with the positioning of the extensions
that are relatively disordered without E3 and become ordered when it is present.
82 Architecture of the Human PDC Core Assemblythe rE2/E3BP map is lowered by ∼30%, additional
density present beyond the core surface is revealed
(Fig. 9c). Like the rE2/E3BP:E3 spikes, these
densities are positioned on either side of the
icosahedral 2-fold axis and align well with each
other when the complexes are positioned within the
common reference frame of their symmetry (Fig. 9c).
This strongly suggests that the spikes in both mapsderive, at least in part, from the same molecular
components. It appears that the addition of E3 to the
complex makes these extension regions more
ordered, so that they are properly resolved on
cryo-EM reconstruction. Furthermore, these spikes
observed on the surface of the rE2/E3BP core at a
lower contour level (Fig. 9c) are in the same
positions as the linking density seen in the cryo-
83Architecture of the Human PDC Core AssemblyEM structure of the bovine kidney PDC core.36 We
also compared the reconstructions to the SAXS-
derived rE2/E3BP model computed ab initio using
GASBOR. There is excellent agreement between the
maps (Fig. 9d; see Materials and Methods for more
details), and the cryo-EM data therefore strongly
support the SAXS-derived model described above.
The extensions from the core surface are longer in
the SAXS model than in the cryo-EM models, but
this derives from the different nature of the two
techniques (see Discussion). Importantly, the bind-
ing of E3 to the E2/E3BP core results in increased
density on the outside of the core icosahedron, in
good agreement with earlier SAXS observations.37
Assessment of core stability
The trimeric building blocks that make up the core
of PDC serve as key elements for core stability.28
Cryo-EM studies of the yeast E2 core revealedFig. 10. Recombinant core stability analysed via CD and
unfolding curves represented by the change in ellipticity at 28
all three cores (rE2/E3BP, rE2 and tE2/E3BP). (b) c(s) distribut
collected over a range of sample concentrations, along with
independent sedimentation coefficient for the main species (s2
0
rE2) with 2.85 M GdmCl indicates differences in the elution pr
putative trimers of tE2/E3BP (arrow) are shown. (d) The
fluorescence spectroscopy as a function of GdmCl concentratio
cores at 2.6, 3.1 and 1.75 M GdmCl, respectively. The wavelen
from 0 to 6 M GdmCl.variation in intertrimer distances, interpreted as
‘breathing’ of the core.31 Interestingly, integration of
E3BP as an additional core subunit in eukaryotic
PDCs may result in structural changes that mediate
intertrimer distances and overall core stability. In
this context, a comparative study of the core
stabilities of rE2/E3BP, rE2 and tE2/E3BP was
conducted using CD and fluorescence spectroscopy
in the presence of the chemical denaturant GdmCl.
Near-UV CD spectra of the cores in the presence of
increasing concentrations of GdmCl resulted in loss
of minima at 285 nm, with complete loss of structure
observed by 6 M GdmCl. Unfolding/dissociation
monitored via measurement of the total change in
ellipticity at 285 nm indicated a high degree of
structural perturbation of the cores in the near-UV
region, with midpoints of unfolding being 2.70 M
(rE2/E3BP), 2.88 M (tE2/E3BP) and 3.19 M (rE2)
GdmCl (Fig. 10a). At concentrations less than 3 M
GdmCl, a gradual unfolding/dissociation event isfluorescence spectroscopy. (a) Comparative near-UV CD
5 nm in the presence of increasing quantities of GdmCl for
ion derived from SV interference data for full-length rE3BP
(inset) determination of the standardised concentration-
0,w=2.51±0.02 S). (c) GFC of purified cores (tE2/E3BP and
ofile. Elution peaks corresponding to void volume (⁎) and
percent change in unfolding monitored by tryptophan
n indicates 50% of unfolded rE2/E3BP, rE2 and tE2/E3BP
gth (380 nm) was chosen as it showed a progressive trend
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ellipticity. This is followed by an abrupt change
beyond 3 M GdmCl that leads to complete unfold-
ing/dissociation of the assembly.
The initial structural change (1.5–3 M GdmCl)
may be attributed to the overall dissociation of
the 60-meric cores to trimers, which then disso-
ciate to monomers before complete unfolding (N3 M
GdmCl).57 The peak at 285 nm corresponds to
spectral contribution from aromatic amino acid
residues (such as tryptophan and tyrosine) and is
rapidly lost with increasing GdmCl concentration.
This may be attributed to conformational changes in
the environment of aromatic residues, resulting in
alterations to the overall tertiary structure during
unfolding/dissociation. In addition, sigmoidal
curves (Fig. 10a) suggest unfolding via some inter-
mediates, consistent with previously published
refolding studies on bE2/E3BP.57 Additionally, the
Gibbs free energy of unfolding ΔG of the cores was
determined to be 17.0 kJ/mol (rE2/E3BP), 23.6 kJ/
mol (rE2) and 11.0 kJ/mol (tE2/E3BP) (data not
shown), further corroborating the unfolding trend as
observed from the near-UV CD data. In summary,
stability curves obtained from near-UV CD indicate
that rE2 is more stable than tE2/E3BP, which in turn
is more stable than rE2/E3BP, suggesting destabili-
sation of the core upon integration of E3BP.
This is further supported by SV AUC data for full-
length E3BP (rE3BP) indicating a predominant
monomeric species (s20,w
0 =2.51±0.02 S) and a small
fraction of possible dimer (Fig. 10b). SE data for
rE3BP could be well fitted by a two-species model
with a major species of Mw
0 =49.6 kDa, in good
agreement with the molecular mass calculated from
the amino acid sequence (51,636 Da), and by a minor
species with a molecular mass lower than that of an
rE3BP dimer (data not shown). The SE data could not
be satisfactorily fittedwith self-associationmodels in
SEDPHAT, suggesting the formation of minor
irreversible aggregates rather than higher oligomers.
In summary, the AUC data show conclusively that
rE3BP, unlike rE2, does not spontaneously self-
associate to form 60-meric cores, but in fact remains
largely monomeric in solution. This is consistent
with a role for rE3BP in destabilising rE2/E3BP
complexes, since any trimer–trimer interaction that
involves contact between rE3BP molecules is likely
to be much weaker than the strong rE2–rE2 interac-
tions that are key to the spontaneous formation of
rE2. These findings lend strong support to the
hypothesis that E3BP destabilises the E2/E3BP core
assembly.
The difference in core stability between rE2 and
tE2/E3BP was additionally confirmed by gel filtra-
tion in the presence of 2.85 M GdmCl, close to the
midpoint of unfolding for tE2/E3BP (2.88 M) but
relatively far from that for rE2 (3.19M). Gel-filtration
profiles indicate void volume elution (40 ml) of the
intact 60-meric cores of both tE2/E3BP and rE2 (Fig.
10c). However, an additional peak at 62 ml is
observed only with tE2/E3BP. Previous refolding
studies by McCartney et al. showed the possibleformation of trimers and monomers during the
unfolding of bE2/E3BP.57 The apparent molecular
mass of the additional tE2/E3BP peak is 185 kDa,
consistent with the presence of E2 homotrimers
(183 kDa) and/or E2/E3BP heterotrimers (2E2
+1E3BP; 174 kDa). It is interesting to note that, at
2.85 M GdmCl, while the gel-filtered tE2/E3BP
reveals subunit dissociation into trimers, rE2
remains almost intact (Fig. 10c), consistent with the
greater stability of the E2 oligomeric assembly.
Fluorescence spectra were recorded bymonitoring
the intrinsic fluorescence of tryptophans in rE2/
E3BP, rE2 and tE2/E3BP. In rE2/E3BP, there are
four tryptophans in the rE2 subunit (one in outer LD,
one in inner LD and two in CTD) and three in the
rE3BP subunit (one in LD, one in inner linker and
one in CTD). Similarly, in tE2/E3BP, there are two
tryptophans in tE2 and one tryptophan in tE3BP. A
gradual shift of the peak maximum towards higher
wavelengths with increasing concentrations of
GdmCl was observed for all cores. In the fully
folded native state, the peak is at 328–331 nm,
indicative of tryptophans buried in the core. Increas-
ing amounts of GdmCl drove a gradual redshift
beginning at 1.5 M (rE2/E3BP) and 1.75 M (tE2/
E3BP) GdmCl and resulting in a shift to 334 nm,
suggesting local dissociation and partial solvent
exposure of tryptophans. On increasing the concen-
tration of GdmCl further, a dramatic shift of the
maximum emission peak to 352 nm was observed at
2.5 M (rE2/E3BP and tE2/E3BP) and 3 M (rE2)
GdmCl, progressing to 360 nm by 6 M GdmCl,
suggesting complete solvent exposure of all trypto-
phans brought about by the overall unfolding/
dissociation of the cores (data not shown).
In summary, the early changes in the observed
tryptophan fluorescence between 0 and 2 MGdmCl,
indicative of local perturbation in structure and/or
formation of trimeric intermediates, are similar to
previous studies of bE2/E3BP demonstrating the
formation of trimeric intermediates between 1.8 and
2 M GdmCl.57 This is immediately followed by a
phase of rapid denaturation, with about 50%
unfolded/dissociated core observed by 1.75 M
(tE2/E3BP), 2.6 M (rE2/E3BP) or 3 M (rE2) GdmCl
(Fig. 10d), corresponding to an overall unfolding
event with a major loss of quaternary and secondary
structures. This trend in unfolding observed by
fluorescence correlateswell with that observed in the
near-UV CD data (Fig. 10a). As fluorescence
emission is a combination of signals from all
tryptophans, it is not possible to draw conclusions
about detailed structural changes in rE2/E3BP and
rE2. However, as LDs and SBDs are missing from
tE2/E3BP, it is possible to conclude that in the range
of GdmCl corresponding to the dissociation of the
overall quaternary structure into trimeric intermedi-
ates, the change in emissionwavelength is accounted
for solely by changes in the environment of the inner
CTD tryptophans.
It is also interesting to note that the intensity
changes for the full-length (rE2/E3BP and rE2) cores
differ from those for tE2/E3BP. An initial decrease
85Architecture of the Human PDC Core Assemblyin fluorescence intensity at low GdmCl concentra-
tions, followed by a gradual increase primarily
associated with the exposure of N-terminal domain
tryptophans to solvent, was observed for full-length
cores (data not shown). This is likely to contribute
greatly to the observed redshift. In contrast, the
steady increase in fluorescence with increasing
GdmCl concentrations for tE2/E3BP was probably
due to the gradual exposure of the CTD tryptophans
that may be largely quenched in the folded state
(data not shown).Discussion
New insights into the basic architecture and
general properties of E2/E3BP core assembly
Although recombinant human and yeast truncat-
ed E2 core structures have been determined previ-
ously by cryo-EM,29,32,35 there is no corresponding
structure for the functional human E2/E3BP core (or
any full-length E2/E3BP core) to date. Recombinant
human or native bovine E2/E3BP cores have
resisted crystallisation, owing primarily to the
intrinsic flexibility of their N-terminal flanking
regions and the difficulties in obtaining high yields
of truncated E2/E3BP; consequently, our under-
standing of the structure–function relationships in
the human PDC core has remained limited.
Attempts to obtain truncated E2/E3BP have always
employed limited proteolysis of the core with
trypsin.58 Yu et al. have been successful in producing
only minimal yields of recombinant human truncat-
ed E2 for structural studies.32 In contrast, high yields
(5–8 mg/l bacterial culture) of pure recombinant
full-length E2, E2/E3BP and tE2/E3BP were suc-
cessfully obtained in this study and used for
structural characterisation.
Our SAXS and SANS models represent the first
solution structures for full-length recombinant and
native bE2/E3BP. Native bovine and recombinant
human assemblies are indistinguishable from each
other at this resolution, indicating that the intact 60-
meric recombinant human E2/E3BP core, with its
characteristic pentagonal dodecahedral framework,
can assemble successfully in Escherichia coli. The
existence of a characteristic 60-meric core formed
from a combination of E2 and E3BP subunits is in
agreement with an early EM reconstruction for
bovine PDC;42 moreover, superimposition of the
tE2/E3BP SAXS model on the crystal structure for
truncated B. stearothermophilus E2 reveals that the
overall dimensions and basic underlying morphol-
ogy are conserved in the mixed E2/E3BP subunit
core assembly.
Interestingly, both full-length bovine and human
E2/E3BP structures feature elongated ‘arms’ ema-
nating outwards from an icosahedral inner core
with empty pentagonal faces. These protruding
‘arms’ account for approximately 40% of the overall
Dmax (480 Å) for rE2/E3BP (as opposed to 300 Å fortE2/E3BP). They are also notably absent from the
corresponding tE2/E3BP SAXS model and thus
represent the first direct visualisation of the N-
terminal flexible LDs and SBDs of E2 and E3BP
within the context of an intact, fully assembled ‘core’
structure. In addition, the presence of open (unoc-
cupied) pentagonal faces is a striking common
feature of all three core reconstructions, lending
further strong support to the ‘substitution’model of
subunit organisation, and in direct contrast to the
earlier ‘addition’ model proposed for yeast E2/
E3BP.35 The overall dodecahedral morphology with
empty pentagonal faces was further confirmed by
negative staining and cryo-EM of the rE2/E3BP
assembly.
This study also reports on novel features of the
first cryo-EM images of rE2/E3BP on its own, as
well as complexed with E3. In addition to confirm-
ing the presence of unoccupied pentagonal faces,
these reconstructions resolve density deriving from
the regions of E2 and E3BP extending above the
main core, which are absent from published crystal
structures. The location of these extensions agrees
extremely well with the positioning of the linking
density previously reported for cryo-EM of the
bovine kidney PDC core,36 as well as with the
equivalent regions of the ab initio GASBOR SAXS
model of rE2/E3BP, reinforcing the validity of this
structure. Furthermore, addition of E3 renders these
extensions much more ordered, as evidenced by the
appearance of well-defined spikes, although they
are not resolvable to the same distance from the core
surface as envisaged via SAXS, reflecting basic
differences in the structural detail provided by
cryo-EM and small-angle scattering (SAS) techni-
ques (see the text below). Previous quasi-elastic light
scattering and cryo-EM studies of the bovine heart
and kidney PDC also established that E2/E3BP
cores have an icosahedral framework with pentag-
onal faces42 and amaximumdimension of≈400 Å.59
However, the anticipated high level of flexibility of
the outer N-terminal domains precluded their
resolution in EM micrographs. Additionally, only
the maximum dimensions of bovine heart PDC core
and its associated E2/E3BP core were obtained from
the quasi-elastic light scattering studies.
Our complementary SE analyses also lend strong
support to the substitution model of core organisa-
tion, as the observed molecular mass of rE2/E3BP is
lower than that of rE2, consistent with earlier
observations by Hiromasa et al.37 Substitution of
E2 by E3BP in the 60-meric core reduces the overall
mass because the E2 polypeptide has an Mr lower
than that of E3BP. Both rE2 and rE2/E3BP have high
frictional ratios (f/f0) and large hydrodynamic radii
(Rs), largely due to the solvent-exposed elongated
outer linkers and LDs of E2 and E3BP and the
presence of open hollow faces.59 Interestingly, it is
observed that f/f0 and Rs for rE2 in our study are
higher than those for rE2/E3BP, in direct contrast
with previously reported AUC data for these
cores.37 This is likely to be a consequence of the
highly anionic nature of the N-terminal domains of
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large number of amino acids (N120) in the flexible
linker regions of E2 that connect the various
domains, and the high alanine and proline contents
of these linkers (Fig. 1).
Our current data also provide the first evidence
relating to the oligomeric state and capacity for self-
assembly of recombinant full-length E3BP produced
as an independent species, since in vivo, this
polypeptide exists exclusively in association with
E2 as an integral subunit of the core assembly.
Interestingly, despite its significant homology
(∼50%) and similar domain organisation to E2,
E3BP is largely monomeric in solution, exhibiting
only a weak tendency for irreversible aggregation.
These experimental data support a prediction, based
on an analysis of sequence alignments and bacterial
E2 crystal structures, that E3BP will lack key
residues/motifs involved in self-assembly and the
hydrophobic ‘ball-and-socket’ joints responsible for
intertrimer interactions. These E2-mediated contacts
are vital to the integrity and stability of the 60-meric
pentagonal dodecahedron assembled from the
coalescence of 20 basic trimeric units. However, in
contrast to extensive interdigitated associations
among the E2 monomers within trimeric units, the
contacts between adjacent trimers are very limited.28
The presence of E3BP as an integral component of
trimeric units (as predicted by the ‘substitution
model’) should further weaken intertrimer interac-
tions, since E3BP lacks the key residues involved in
mediating trimer–trimer contacts.37
Our current data from AUC (for full-length
rE3BP), CD and fluorescence spectroscopy studies
(on full-length and truncated E2/E3BP and full-
length E2) provide the first direct evidence in
support of the above hypothesis. Near-UV CD
spectroscopy in the presence of GdmCl clearly
shows unfolding via intermediates, in good agree-
ment with previous unfolding studies of the bE2/
E3BP57 demonstrating initial dissociation into puta-
tive trimers and strongly suggesting that the
introduction of E3BP into the E2 core has a
significant effect on its stability. Thus, lower
GdmCl levels were required to induce disruption
of intact rE2/E3BP and tE2/E3BP compared with
rE2. The higher stability of rE2 (compared with rE2/
E3BP or tE2/E3BP) is clearly reflected in their
midpoints of unfolding, as well as in an analysis of
trimer formation by GFC, further supporting the
hypothesis of decreased E2/E3BP core stability.
Moreover, early changes in core fluorescence (at low
GdmCl concentrations) prior to large-scale disrup-
tion of secondary structure reflect the partial
dissociation of the 60-meric core leading to the
release of putative trimers.
Current core E2/E3BP models also highlight the
presence of large internal solvent-filled cavities,
which are characteristic features of these eukaryotic
assemblies. The elevated Dmax (300 Å) of tE2/E3BP
obtained by SANS, compared with that previously
observed for tE2 cores (225–272 Å),31,42,60 may
reflect a greater size heterogeneity or extent of‘breathing’ in E2/E3BP. As the concept of breathing
has been studied only with the yeast E2 core,31 it is
unclear how it modulates the size, flexibility and
function of human E2/E3BP, and, more specifically,
how the introduction of E3BP affects these process-
es. It has been speculated that breathing of the core
enhances the movement of the lipoyl ‘swinging
arms’ towards the catalytic centres, while addition-
ally augmenting substrate channeling. In addition,
the new structures of the E2/E3BP cores presented
here suggest that access to the active sites by the LDs
will be further boosted by the open topology of the
empty faces. These architectural features are sug-
gested to enhance the overall rates of catalysis.31
Comparison of cryo-EM and SAXS images:
Technical considerations
Cryo-EM images are inherently noisy, and signal
is recovered by assigning relative orientations to
objects and combining them into single three-
dimensional volumes. This averaging smears out
any features not consistently positioned on the
images. Application of symmetry constraints smears
out anything not following the symmetry, whether
due to disorder or partial occupancy. If partial
occupancy is the reason, then the shape of the object
is consistently present, but its level of density
compared with the rest of the structure is reduced
because it is averaged against empty binding sites.
Thus, use of a lowered contour level can allow the
recovery of an impression of the partially occupied
structure. The need for a lower contour level to
recover the density observed when E3 binds to the
core (Fig. 9c) is consistent with partial occupancy of
the sites to which E3 binds, in comparison with the
total number of projections recovered. The volume
occupied by this density is consistent with the
volume of an E3 dimer plus an associated dimer of
the E3BP SBD and linker; however, interestingly, the
atomic resolution structure of the E3 dimer com-
plexed with E3BP SBD61,62 does not satisfactorily
superimpose with the density. This suggests that the
interaction observed between E3 monomers in the
crystal may not reflect the interactions on the PDC
core surface. This disagreement could stem from the
presence of E3 cross-bridges linking pairs of E3BP
dimers on the core surface.
Cryo-EM maps that suffer from partial occupan-
cy/disorder will display noisy features that cannot
be distinguished rigorously from literal noise in the
background of the image as the contour is lowered.
These are therefore typically ignored. However,
solution SAS data represent a spherical average of
the sample object. These are modelled as a set of
discrete ‘atoms’, in the case of PDC, according to
symmetry. In this method of volume reconstruction,
the statistical presence of a feature separated from
the main body of the structure (which appears as
noise in a cryo-EM map) is referenced by the
presence of an ‘atom’. Since the ‘atoms’ are discrete
objects, they allow such features to be represented
separately from background noise, which is not
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further lowering the contour level of the cryo-EM
reconstructions (Fig. 9c) does reveal density extend-
ing far from the core surface, as the SAXS model
does and as previously noted63 (data not shown),
but we prefer to concentrate on the portions of the
structure that we can characterise with confidence,
and these agree with the regions of the extension
structures near the core surface in the scattering
model.
An additional feature is that in the imaging of an
object by cryo-EM, no a priori decision can be taken
as to what is signal and what is noise, and the image
formation process inevitably suffers from effects of
inelastic scatter, sample movement and inaccurate
correction of contrast transfer function (CTF). There
is no CTF in SAS: this is the reason that SAS data can
be used to correct the amplitude component of the
CTF. The assumption of spherically averaged data
in SAS aids in signal-to-noise ratio; however, in
cryo-EM, the views obtained are considered to be
specifically defined orientations and cannot be
averaged with other views without an orientation
assignment being made, which is itself subject to
artifacts associated with noise. Taken together, these
findings strongly support the hypothesis that cryo-
EM imaging misses key features that can be detected
by SAXS studies.Concluding Remarks
In summary, this work provides important new
insights into the structural organisation and general
features of the E2/E3BP core assembly of mamma-
lian PDC (a) by an analysis of several recombinantly
produced and native core variants and (b) by a
comparison of the SAXS/SANS and cryo-EM
structures for these assemblies. These models all
display a common pentagonal dodecahedral frame-
work with open pentagonal faces that are, at the
resolution attained, indistinguishable in overall
geometry and dimensions from the crystal structure
for the E2-only core of B. stearothermophilus. They
also provide definitive evidence in support of the
‘substitution model’ of core organisation in which
E3BPs replace an equivalent number of E2s within
this 60-meric assembly rather than being located on
its 12 pentagonal faces, as envisaged in the earlier
‘addition model’. However, these low-resolution
structures still do not permit E2 subunits to be
distinguished from their E3BP counterparts and
thus are unable to provide information on the
overall subunit composition or precise locations of
E3BPs within the core.
An advantage of this approach, however, is that it
has permitted the first direct visualisation of the
peripherally extended N-terminal arms of E2 and
E3BP encompassing their LDs and SBDs, joined by
flexible linkers in the context of an intact core
assembly. In addition, by comparison with cryo-EM
images of the E2/E3BP core in the presence and in
the absence of bound E3, it is possible to identifythose regions immediately above the core surface
housing the SBDs. Moreover, these EM reconstruc-
tions have revealed that E3 induces striking changes
in this region, as evidenced by the appearance of
well-defined spikes. These indicate the formation of
more ordered structures that are compatible with
the existence of a network of E3 cross-bridges
linking pairs of E3BPs around the core surface, as
proposed previously by our group.69 Finally, the
ability to produce rE3BP both as an independent
polypeptide and in recombinant E2/E3BP cores has
allowed assessment of its oligomeric state, its
inherent capacity for self-association and monitor-
ing of its effects on core assembly and stability. In
contrast to E2, E3BP shows no capacity for reversible
self-association and exists largely as a monomeric
species in solution. In line with this observation,
inclusion of E3BP within the core assembly appears
to decrease overall core stability. However, its
contribution to mediating core dynamics, the overall
rates of catalysis, the phenomenon of ‘breathing’
and the observed size heterogeneity of the mamma-
lian core assembly remain to be established.
An urgent priority is to distinguish between the
current 48+12 model and the current 40+20 model
for the E2BP core assembly, requiring determination
of the number and distribution of E3BPs within the
mammalian core structure. However, this is a
challenging task and requires novel approaches to
the problem. Single-molecule studies and/or cryo-
EM of the E2/E3BP core complexed with a mono-
clonal antibody to E3BP offers hope for this in the
near future. In addition to validating the subunit
composition of the E2/E3BP core, these techniques
should also provide more detailed information on
the molecular basis of core heterogeneity, size
variation and intrinsic protein dynamics.Materials and Methods
Cloning of tE2/E3BP
The C-terminal constructs of mature E2 and E3BP (tE2
and tE3BP) typically encompassed the C-terminal region
and several additional residues of the preceding linker
region. Primers were obtained fromMWG Biotech (UK) to
enable isolation of the C-terminal clones tE2 (aa 398–613)
and tE3BP (aa 245–501). While tE2 was cloned into the
NdeI and BamHI sites of vector pET11b via the TOPO/TA
Cloning System (Invitrogen), tE3BP was cloned directly
into pET28b using the restriction sites BamHI and XhoI via
the classical cloning approach. All PCR products and
purified DNA were analysed on a 1% (wt/vol) agarose
gel. Successful cloning of inserts was confirmed by
diagnostic digests and DNA sequencing of recombinant
plasmids.
Expression and purification of rE2/E3BP, rE2,
and tE2/E3BP
The recombinant cores rE2 (in pET14b), rE2/E3BP and
tE2/E3BP (in pET11/pET28b) and full-length E3BP
(rE3BP) were overexpressed in the E. coli strain BL21 star
88 Architecture of the Human PDC Core Assembly(DE3) (Invitrogen) and grown in LB media (500 ml)
containing 100 μg/ml ampicillin (rE2, rE2/E3BP and tE2/
E3BP) and 25 μg/ml kanamycin (rE2/E3BP, tE2/E3BP
and rE3BP). Bacteria were grown at 37 °C to an OD600 of
0.6–0.8 and subsequently induced with 1 mM IPTG for
17 h at 18 °C (rE2) and 15 °C (rE2/E3BP, tE2/E3BP and
rE3BP). On induction, the rE2, rE2/E3BP and rE3BP
cultures were further supplemented with 50 μg/ml lipoic
acid. Cells were then harvested by centrifugation at
10,000g for 15 min at 4 °C, and overexpression was
analysed by SDS-PAGE. Frozen cell pellets were resus-
pended in 20 ml of metal chelate binding buffer [100 mM
NaCl, 10 mM imidazole, and 50 mM KH2PO4 (pH 8.0)]
supplemented with Complete EDTA-Free Protease Inhib-
itor Tablets (Roche), DNase I (Sigma) and Halt Protease
Inhibitor Cocktail (10 μl/ml binding buffer; Thermo
Scientific). Cells were lysed in a French pressure cell at
950 psi and subsequently centrifuged at 10,000g for 15min
at 4 °C. The soluble supernatant was removed, filtered
through a 0.2-μm syringe filter and injected onto a zinc
metal chelate affinity column (20MC) on the BioCAD
Sprint or BioCAD 700E chromatography workstations
(Applied Biosystems, USA). While the N-terminal His tag
is present in rE2 and rE3BP, it is located only in E3BP in the
rE2/E3BP and tE2/E3BP complexes. Proteins were eluted
as 1.5-ml fractions with a 0–100% imidazole gradient of
elution buffer [100 mM NaCl, 500 mM imidazole and
50 mM KH2PO4 (pH 6.0)], and yield and purity were
analysed by SDS-PAGE. Protein fractions were then
pooled and subjected to either anion-exchange chroma-
tography (rE2, rE2/E3BP) or gel filtration (tE2/E3BP and
rE3BP) for further purification.
Pooled fractions of rE2 and rE2/E3BP from the metal
chelate column were exchanged into dialysis buffer [2 mM
ethylenediaminetetraacetic acid (EDTA), 450 mM NaCl
and 25 mM Tris–HCl (pH 7.5)] and subjected to 20HQ
anion-exchange chromatography (Applied Biosystems)
for selective removal of DNA. The column was equili-
brated with binding buffer [2 mM EDTA and 25 mM Tris–
HCl (pH 7.5)], and protein was eluted via a 0–100%
gradient of elution buffer [2 mM EDTA, 2 M NaCl and
25 mM Tris–HCl (pH 7.5)]. Protein obtained from anion-
exchange chromatography (rE2 and rE2/E3BP) or metal
chelate chromatography (tE2/E3BP and rE3BP) was
pooled, concentrated and further purified by GFC on a
Sephacryl S-300 column (Amersham, USA) equilibrated
with PEBS100 buffer [2 mM EDTA, 0.01% (wt/vol) NaN3,
100 mM NaCl and 50 mM KH2PO4 (pH 7.5)]. Absorbance
was monitored at 260 and 280 nm, and protein fractions
(2 ml/tube) were analysed by SDS-PAGE. The concentra-
tion of the purified cores was measured at 280 nm on an
Ultrospec 4300 Pro UV/Vis spectrophotometer. The
extinction coefficients of the cores calculated from protein
sequences via PROTPARAM† were 20,970 M−1 cm− 1
(rE3BP), 2,124,600 M− 1 cm− 1 (rE2), 1,951,320 M− 1 cm− 1
(rE2/E3BP) and 862,200 M− 1 cm−1 (tE2/E3BP) based on
the 48E2+12E3BP model.
Purification of bovine heart PDC core and bovine
E2/E3BP core
PDC was purified from bovine heart essentially as
described before64 and involved biasing the maximum
yield of PDC (without any OGDC contamination) by a
final precipitation step adding 0.06 vol of 35% (wt/vol)†http://expasy.org/tools/protparam.htmlPEG. PDC concentration was determined using the
Bradford assay and was stored in small aliquots (at
10 mg/ml) in 50% (vol/vol) glycerol at −20 °C for future
use. Bovine E2/E3BP core (bE2/E3BP) was extracted from
PDC by discontinuous sucrose gradients as described
earlier,58 with the following changes: 4 ml of 20% (wt/vol)
sucrose, 2 ml of 10% (wt/vol) sucrose and 2 ml of 5% (wt/
vol) sucrose in PEBS2M buffer [2 M NaCl, 2 mM EDTA,
0.01% (wt/vol) NaN3, 1% (vol/vol) Triton X-100 and
50 mM KH2PO4 (pH 7.4)] were layered one above the
other. Bovine heart PDC (5–8 ml) was layered on the
sucrose gradients and ultracentrifuged in a Beckman Ti70
rotor at 182,000g at 4 °C for 150 min. Supernatant fractions
(1 ml) were collected from the top using a peristaltic
pump, and the bE2/E3BP pellet was suspended in storage
buffer as mentioned above. The protein concentration of
bE2/E3BP was measured using the Biuret method at
550 nm.
Analytical ultracentrifugation
SV experiments were performed on a Beckman Coulter
Optima XL-I analytical ultracentrifuge (Beckman Coulter,
Palo Alto, CA, USA) using an An-50 Ti eight-hole rotor.
Samples (360 μl) at concentrations from 76 to 306 nM (rE2/
E3BP), 60 to 260 nM (rE2), 116 to 730 nM (tE2/E3BP) and
1.94 to 58.1 μM (rE3BP), along with PEBS100 buffer [2 mM
EDTA, 0.01% (wt/vol) NaN3, 100 mM NaCl and 50 mM
KH2PO4 (pH 7.5)] as reference solvent, were loaded into
12-mm path-length charcoal-filled epon-double-sector
centrepieces and spun at 20,000 rpm (rE2, rE2/E3BP and
tE2/E3BP) and 45,000 rpm (rE3BP) at 4 °C, and a series of
scans was collected using either interference optics,
absorbance optics or a combination of both. Data were
recorded over a radial range of 6.0–7.25 cm, and a radial
step size of 0.002 cm was used in the case of absorbance
optics. For interference optics, 450 scans were recorded
1 min apart, and laser delay was adjusted prior to the run
to obtain high-quality interference fringes. Data were
analysed using the program SEDFIT.65,66 Sedimentation
boundaries were initially modelled as numerical finite-
element solutions of the Lamm equation using the c(s)
analysis. Apparent sedimentation coefficients were fur-
ther obtained via the non-interacting discrete species
model that employs finite-element analysis. The apparent
sedimentation coefficients were then corrected to standard
conditions of temperature and solvent before being
extrapolated to infinite dilution to obtain a sedimentation
coefficient independent of concentration, s20,w
0 . The partial
specific volume v̄ of rE2/E3BP and rE2 calculated from
their amino acid compositions using the program
SEDNTERP‡67 was 0.744 ml/g at 20 °C, while those of
tE2/E3BP and rE3BP were calculated to be 0.746 and
0.742 ml/g, respectively, at 20 °C. As both SV absorbance
and interference data yielded the same results, only
interference data have been presented in this work, unless
otherwise stated.
SE experiments were conducted in a Beckman Coulter
Optima XL-I analytical ultracentrifuge using an An-50 Ti
eight-hole rotor at speeds of 3000, 5000 and 7000 rpm.
However, analysis of the data at 5000 and 7000 rpm was
unsatisfactory, yielding very steep exponential solute
distributions. Hence, all subsequent SE studies were
performed at 3000 rpm, unless otherwise stated. All
experiments were carried out at 4 °C, with protein samples
(80 μl) at various concentrations from 154 to 461 nM (rE2/‡http://www.jphilo.mailway.com/
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loaded into 12-mm path-length charcoal-filled epon-
double-sector centrepieces. PEBS100 buffer was used as
reference solvent. After an initial delay of 20–24 h, a series
of scans (12–15) separated by 3 h was recorded using
interference optics. Data were recorded over a radial range
of 6.8–7.25 cm, with the laser delay adjusted before the
run. The programWinMATCH§ was used to confirm that
the system had reached equilibrium, and the SE data were
analysed using the program SEDPHAT.43,44 Single data-
set analysis was performed for every concentration to
obtain an apparent whole-cell weight-average molecular
mass, Mapp. The average molecular mass independent of
concentration was determined by plotting 1/Mapp versus
concentration, with the y-intercept yielding the whole-cell
average molecular mass at infinite dilution Mw
0 .
Small-angle X-ray scattering
SAXS experiments were performed on beamline X33 of
the European Molecular Biology Laboratory (EMBL)/
Deutsches Elektronen Synchrotron (Hamburg, Germany).
Data were collected in mica sample holders at various
sample concentrations (rE2/E3BP: 140.8, 830.9 and
1070.4 nM; bE2/E3BP: 183.1 and 321.1 nM) and tempera-
tures (10, 20 and 37 °C) at a detector distance of 4 m over a
momentum transfer range of 0.008bsb0.497 Å− 1 (where
s=4πsinθ/λ). The 345-mm two-dimensional MAR image
plate detector was calibrated using bovine serum albumin
as standard prior to the experiment. Each data set was
recorded over a period of 4 min, with data for buffer
(PEBS100) collected before each sample. Scattering data
were integrated, normalised to the main incident beam
and detector response, and processed using the program
PRIMUS‖.68 Scattering curves were assessed for radiation
damage, and those unaffected by aggregation were then
averaged, buffer subtracted and scaled for concentration
using PRIMUS. The final average buffer-subtracted curve
was inputted to GNOM,47,48 and the p(r) distance
distribution plots and maximum dimension Dmax of the
proteins were determined. The radius of gyration Rg was
obtained from Guinier analysis (in PRIMUS) and GNOM.
Small-angle neutron scattering
SANS was conducted on beamline D22 of the Institut
Laue Langevin (ILL; Grenoble, France). Samples were
measured in protein buffer (PEBS100) at detector distances
of 4 and 14 m, covering an overall Q range of
0.0034bQb0.143 Å− 1 (where Q=4πsinθ/λ). Scattering
data were recorded at 4 °C in 1-mm path-length quartz
cuvettes at protein concentrations of 1039.4 nM for rE2/
E3BP and 161.7, 353.3 and 712.6 nM for tE2/E3BP.
Transmission and scattering data for buffer and sample
at both detector distances were collected for 4 and 15 min,
respectively. The response of the two-dimensional area
gas detector was calibrated by measuring the scattering of
H2O. While the Unix program MAD was used to control
data acquisition, the GUI program GRASansP written by
Charles Dewhurst (ILL)¶ was employed for graphical§http://www.rasmb.bbri.org/rasmb/windows/
uconn_uaf/
‖http://www.embl-hamburg.de/ExternalInfo/
Reasearch /Sax/software.html
¶ http://www.ill.eu/instruments-support/instruments-
groups/groups/lss/grasp/home/inspection, analysis and reduction of raw data. The p(r)
distance distribution, maximum dimension Dmax and
radius of gyration Rg were obtained using the programs
PRIMUS and GNOM, as described above.
Ab initio modelling of SAXS and SANS data
All ab initio reconstructions of molecular envelopes
from SAXS and SANS data were generated using the
program GASBOR.49,50 Icosahedral (PICO) symmetry
was applied with no constraint on disconnectivity and
peripheral penalties during the modelling process. As
GASBOR runs were extremely time intensive (10 days on
a desktop PC) due to the large size of the cores, 100–
200 simulations/protein were conducted in batch mode
using the powerful computer grid system SCOTGRIDa.
Each simulation on SCOTGRID took approximately
7 days to complete on a single computer node. GASBOR
models of tE2/E3BP were superimposed and averaged
by the program DAMAVER51 to obtain a consensus
average structure. However, averaging 10 ab initio
models of rE2/E3BP and bE2/E3BP to obtain consensus
structures posed significant problems on account of
hollow cavities within the cores and peripheral regions
of elongated density (from SBDs and LDs) within the
same structure. Nevertheless, as volumes obtained from
CRYSOL56 (4.3–4.37×106 Å3) for each reconstruction
compared favourably with the calculated volumes of
the cores (4.38×106 Å3), representing consensus models
of rE2/E3BP and bE2/E3BP by the superimposition of 10
ab initio GASBOR models proved to be a feasible
approach to overcoming the problem of structure
restoration encountered with DAMAVER.
Negative-stain EM
Negative-stain EM was performed on a 1200 EX
scanning microscope (JEOL, Japan) at an operating
magnification of 30,000× and with an acceleration voltage
of 120 kV. Carbon-coated copper grids (400 mesh; Agar
Scientific Ltd., UK) were initially rendered hydrophilic by
plasma glow discharge, after which 5 μl of protein was
added and loaded onto each grid. The grids were then
sequentially washed with distilled water (50-μl droplets)
and, finally, with a 50-μl droplet of 2% (wt/vol)
ammonium molybdate (pH 7.2) (negative stain; Agar
Scientific Ltd.). Excess liquid was drained from the grids
using Whatman filter paper, and they were then allowed
to air dry. Micrographs of rE2/E3BP and tE2/E3BP were
recorded at sample concentrations of 19.7 and 32 nM,
either at high magnifications (90,000× to 120,000×) on a
Gatan-Erlangshen-lens-coupled CCD camera or under
low-electron-dose conditions at a magnification of
30,000× on Kodak S0163 film. Micrographs recorded on
film were subsequently digitised at 5000 dots/in. using a
Nikon Coolscan 4000 transparency scanner.
Cryo-EM and image reconstruction
E3 used for cryo-EM experiments was expressed and
purified as described elsewhere.69 rE2/E3BP and E3 were
mixed at a ratio of 2:1 (rE2/E3BP:E3). It is to be noted that
the ratio here refers only to the ratio of monomeric E3BP to
dimeric E3 (E3BP:E3); therefore, 2:1 represents 12E3BP:6E3a http://www.scotgrid.ac.uk/
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rE2/E3BP and rE2/E3BP:E3 complexes in vitreous ice
were obtained using an FEI F30 cryo-electron microscope
operating at a magnification of 38,000× and at 300 kV. The
negatives were captured on Kodak SO-163 film and
scanned on a Zeiss SCAI scanner with a raster size of
7 μm, giving a pixel size of 1.8 Å at the specimen. The
images were CTF corrected on a per-micrograph basis
using the EMAN suite program Ctfit, and subsequently
normalised and binned to a pixel size of 3.6 Å using the
EMAN program Proc2d.70 Nine hundred eighty-two
images from 16 micrographs were used for the rE2/
E3BP reconstruction, and 172 images from 9 micrographs
were used for the rE2/E3BP:E3 reconstruction; all
particles were picked interactively using Boxer from the
EMAN suite.70 Reconstructions were initially determined
using the program IMAGIC,71 assuming dodecahedral
symmetry, and then refined in SPIDER,72 making the
same assumption. The reconstructions reported here have
resolutions of 18.3 Å for the rE2/E3BP map and 33.0 Å for
the rE2/E3BP:E3 map. The Fourier shell correlation
criterion for resolution (Fourier shell correlation=0.5)
was used. Maps were filtered, and the SAS model was
prepared for comparison with them using the software
WellMAP (J. F. F. Flanagan, IV and R.J.C.G., unpublished);
this included inverting the hand of the scattering model
since this produced amuch better alignment of the regions
of the structures extending from the PDC core surface. The
maps have been deposited in the PDB Europe structure
database for EM structuresb with accession codes EMD-
1658 and EMD-1659, andwill be released for download on
publication.
Homology modelling and superimposition of cores
A homology model of the recombinant human truncated
E2 (tE2) was obtained from the SWISS-MODEL serverc.68–76
The crystal structure of B. stearothermophilus E2 (PDB ID
1B5S)28 was used as template, and themodelwas submitted
via project mode in the program Swiss-PdbViewerd.74 The
human tE2 model obtained from SWISS-MODEL was a
pentamer, and the complete oligomeric 60-mer was built
using crystallographic symmetrywith the programPyMOL
(Delano Scientific, USA). All structures were visualised
using the programs VMDe,77 Swiss-PdbViewer74 and
PyMOL (Delano Scientific). Superimposition of high-reso-
lution atomic solution structures and low-resolution solu-
tion structures was performed using the program
SUPCOMB,55 employing default parameters.
Hydrodynamic modelling
The programs HYDRO++53,54 and SUPCW78 were
used to calculate the hydrodynamic properties of
atomic resolution structures. HYDRO++ is an improved
version of an earlier program HYDRO,54 with enhanced
calculations for rotational properties and intrinsic
viscosities. Hydrodynamic parameters, including the
anhydrous sedimentation coefficient s0 and the transla-
tional diffusion coefficient Dt, were obtained by providing
an HBM generated from atomic coordinates as an input to
HYDRO++ and SUPCW. The GASBOR-generated ab initiob http://www.ebi.ac.uk/pdbe
c http://swissmodel.expasy.org/
d http://www.expasy.org/spdbv/
e http://www.ks.uiuc.edu/Research/vmd/models of rE2/E3BP and tE2/E3BP were converted into
HBMs employing a 15-Å and 5.7-Å cubic grid using the
AtoB algorithm52 implemented within SOMO,79 now part
of the program ULTRASCANf.80 The HBMs used for
calculations with HYDRO++ were corrected to the exact
volumes of rE2/E3BP and tE2/E3BP, obtained from
calculations based on the molecular mass M, the partial
specific volume v ̄ and Avogadro's number NA
(6.023×1023 mol− 1). Alternatively, HBMs of rE2/E3BP
and tE2/E3BP with no bead overlaps were generated
using a 7-Å cubic grid with the program TRANS2VOR-
ONOI, an extended version of AtoB developed by M.
Nöllmann (Centre de Biochimie Structurale Montpellier,
France), and hydrodynamic computations were per-
formed using the SUPCW subroutine of BEAMS.78
Only surface hydrodynamic hydration is “seen” by
HBM programs such as HYDRO++; solvent entrapped in
central cavities or in empty faces of icosahedra (e.g., in the
case of PDC) does not contribute.52 As a consequence, the
hydration factor applied to correct the computed anhy-
drous sedimentation coefficient is derived from a much
lower level of hydration compared to the maximum
possible value suggested by the frictional ratio.81 The
level of hydration appropriate for correction of s for the
architecturally comparable spherical hollow multi-protein
apoferritin complex was found to be 0.2 g water/g
protein.52 We could not justify choosing this exact value
for correction of PDC sedimentation coefficients; therefore,
a (similar) typical hydration of 0.4 g water/g protein was
used.
Anhydrous sedimentation coefficients obtained from
HYDRO++ and SUPCW were converted into their
equivalent hydrated values by employing a conversion
factor of 0.87 (derived from hydration of 0.4 g water/g
protein using the relationship F = v= v + d1v01
  
1=3,
where δ1 is the hydration and v1
0 is the specific volume
of the solvent).52 All models obtained from AtoB and
TRANS2VORONOI were visualised with one of several
programs: PyMOL (Delano Scientific), RASMOLg82 or
FreeWRLh. AtoB was used to construct HBMs from ab
initio models obtained from SAS data and atomic
resolution structures, while TRANS2VORONOI employed
only the ab initio SAS models for HBM generation.
CD spectroscopy
CD studies (far-UV and near-UV) were performed to
assess the core stability of rE2/E3BP, rE2 and tE2/E3BP in
PEBS100 buffer in the presence of denaturant (0–6 M
GdmCl) at 25 °C. Experiments were conducted on a
JASCO J-810 spectropolarimeter with a 1-nm bandwidth
and with scan speeds and response times of 50 nm/min
and 0.5 s for far-UV, and 10 nm/min and 2 s for near-UV.
Quartz cells (path length, 0.5 and 0.02 cm) were used for
near-UV and far-UV, covering the ranges 250–320 and
180–260 nm, respectively. Data were recorded at sample
concentrations of 0.2 mg/ml (far-UV) and 0.9 mg/ml
(near-UV) for rE2/E3BP, rE2 and tE2/E3BP in the
presence of increasing amounts of GdmCl. GdmCl
concentration was accurately measured via refractometry
prior to each run. The extent of unfolding or dissociation
in the presence of increasing denaturant was monitored at
222 nm (far-UV) and 285 nm (near-UV) by calculating thef http://www.ultrascan.uthscsa.edu/
g http://openrasmol.org
h http://freewrl.sourceforge.net
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free energy at infinite dilution ΔG0 of the unfolding
reactions under standard conditions of temperature and
pressure was also computed. As data obtained from far-
UV and near-UV CD showed similar results, only near-UV
CD data are presented here, unless stated otherwise.
Tryptophan fluorescence spectroscopy
Changes in tryptophan fluorescence were monitored for
rE2, rE2/E3BP and tE2/E3BP samples in PEBS100 buffer
during chemical denaturation in the presence of increasing
concentrations of GdmCl (0–6 M). The cores (0.2 mg/ml)
were excited at 295 nm, and fluorescence emissions were
monitored over the spectral range 310–450 nm using a
Perkin-Elmer L55OB spectrophotometer at 25 °C. Quartz
cells (path length, 1 cm) were used, and data were
analysed with software provided by the manufacturer.Acknowledgements
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